Article Text

PDF
Letter
Prospective evaluation of cataract surgery in female patients taking tamsulosin
  1. Walid Abdelghaffar1,
  2. Ahmed Elsebaey2
  1. 1Ophthalmology Department, Benha University, Cairo, Egypt
  2. 2Urology Department, Benha University, Cairo, Egypt
  1. Correspondence to Dr Walid Abdelghaffar, Benha University, 40 Nehro Street, Heliopolis, Cairo 11341, Egypt; drwalid{at}eyecare-eg.com

Statistics from Altmetric.com

Intraoperative floppy iris syndrome (IFIS) was first described in 2005 by Chang and Campbell in patients undergoing cataract surgery who were taking tamsulosin.1 Tamsulosin is the most commonly prescribed drug for the treatment of benign prostatic hyperplasia. It acts by selectively antagonising alpha-1a adrenergic receptors (α1ARs) found in the bladder neck and prostate smooth muscle, resulting in relaxation of the muscles and improvement of urinary flow. It has the therapeutic advantage of being uroselective and therefore having fewer cardiovascular side effects.2

The use of tamsulosin has been proposed for various urological conditions in women since it has been proved to have a significant relaxing effect on the urethral tone in healthy women in vivo.3

To the best of our knowledge, when we …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.